On April 3, 2018, BIOCND Inc. (XKON:A217950) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29,750 KRW | -1.16% | -2.14% | +48.01% |
1st Jan change | Capi. | |
---|---|---|
+48.01% | 8.9Cr | |
+9.42% | 11TCr | |
+11.84% | 11TCr | |
-2.30% | 2.2TCr | |
-14.15% | 2.19TCr | |
-5.29% | 1.92TCr | |
-4.16% | 1.81TCr | |
-38.29% | 1.77TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.24TCr |
- Stock Market
- Equities
- A217950 Stock
- News PHARMARESEARCH BIO Co., Ltd.
- BIOCND Inc. announced that it has received KRW 10 billion in funding from Pharma Research Products Co., Ltd